Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies

Name: Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies
Published: 2018
License: Public Domain

Anwaar Saeed · 2018

ClinicalTrials.gov · Datasets · License: Public Domain · 2018

Open Source ↗

colorectal-cancer gastric-cancer hepatocellular-carcinoma

gastric cancer, esophageal adenocarcinoma, hepatocellular carcinoma, colorectal cancer, cabozantinib, durvalumab, tremelimumab, interventional, phase1, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies

Related documents